AXL mediates resistance to cetuximab therapy. [electronic resource]
Producer: 20150120Description: 5152-64 p. digitalISSN:- 1538-7445
- Animals
- Antibodies, Monoclonal, Humanized -- pharmacology
- Antineoplastic Agents -- pharmacology
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Carcinoma, Squamous Cell -- drug therapy
- Cell Growth Processes -- drug effects
- Cell Line, Tumor
- Cetuximab
- Drug Resistance, Neoplasm
- Head and Neck Neoplasms -- drug therapy
- Humans
- Lung Neoplasms -- pathology
- Mice
- Mice, Nude
- Proto-Oncogene Proteins -- biosynthesis
- RNA, Small Interfering -- administration & dosage
- Receptor Protein-Tyrosine Kinases -- biosynthesis
- Squamous Cell Carcinoma of Head and Neck
- Transfection
- Xenograft Model Antitumor Assays
- Axl Receptor Tyrosine Kinase
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.